| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/13/2007 | EP1794160A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as proteine kinase inhibitors |
| 06/13/2007 | EP1794155A1 Oxazole derivatives as her tyrosine kinase inhibitors |
| 06/13/2007 | EP1794153A1 1,2,3-triazole derivatives as receptor tyrosine kinase inhibitors |
| 06/13/2007 | EP1794151A1 Dna-pk inhibitors |
| 06/13/2007 | EP1794150A1 Benzimidazole derivatives and their use as cannabinoid receptor ligands I |
| 06/13/2007 | EP1794148A1 Novel phthalazinone derivatives, as aurora-a kinase inhibitors |
| 06/13/2007 | EP1794142A1 A novel compound and a novel microorganism for producing the novel compound |
| 06/13/2007 | EP1794141A1 Substituted chroman derivatives, medicaments and use in therapy |
| 06/13/2007 | EP1794137A2 Specific kinase inhibitors |
| 06/13/2007 | EP1794134A1 Substituted 2-anilinopyrimidines as cell cycle kinase inhibitors or receptor tyrosine kinase inhibitors, production of said substances and use of the latter as medicaments |
| 06/13/2007 | EP1794120A2 Peptidase inhibitors |
| 06/13/2007 | EP1793857A2 Combination therapy with anti-ctla4 and anti-4-1bb antibodies |
| 06/13/2007 | EP1793851A1 Methods and compositions for treatment of hematologic cancers |
| 06/13/2007 | EP1793847A2 Use of microproteins as tryptase inhibitors |
| 06/13/2007 | EP1793846A1 Compositions and methods comprising vitamin b12 and an impdh inhibitor for treating viral, inflammatory and proliferative diseases |
| 06/13/2007 | EP1793843A1 Macrocyclic sh2 domain binding inhibitors |
| 06/13/2007 | EP1793842A2 Treatment for cancer-related fatigue |
| 06/13/2007 | EP1793832A2 Geranylgeranyl pyrophosphate synthase inhibitors |
| 06/13/2007 | EP1793830A2 Therapeutic combinations comprising poly(adp-ribose) polymerases inhibitor |
| 06/13/2007 | EP1793824A1 New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders |
| 06/13/2007 | EP1793823A2 Sulfonyl hydrazines as hypoxia-selective antineoplastic agents |
| 06/13/2007 | EP1793822A1 Tricycles, their manufacture and use as pharmaceutical agents |
| 06/13/2007 | EP1793817A2 Methods of treating a disorder |
| 06/13/2007 | EP1793814A2 Thyroid hormone analogs for promoting angiogenesis |
| 06/13/2007 | EP1793675A2 Salts of decitabine |
| 06/13/2007 | EP1636213B1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity |
| 06/13/2007 | EP1534709B1 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/13/2007 | EP1532139B1 Total synthesis of myriaporones |
| 06/13/2007 | EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1487840B1 Crystalline polymorphic form of irinotecan hydrochloride |
| 06/13/2007 | EP1470146B1 Antibodies against the muc18 antigen |
| 06/13/2007 | EP1424960A4 Removable stent and method of using the same |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1387844B1 Retinol derivatives potentiation of active substances by micellar preparation |
| 06/13/2007 | EP1357944B1 Perylenequinones for use with immunotherapy agents |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1320383B1 Photosensitisers |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1244690B1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 06/13/2007 | EP1083177B1 Compounds capable of cleaving double-stranded dna and method of utilization of the same |
| 06/13/2007 | EP1037989B1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/13/2007 | EP1012304B1 Component of bromelain |
| 06/13/2007 | EP0988060B1 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 06/13/2007 | EP0975354B1 Ligand/lytic peptide compositions and methods of use |
| 06/13/2007 | EP0889972B1 Use of the determination of polymorphims in the promoter region of the TGF-beta 1 gene in diagnosis |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | CN1980938A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 06/13/2007 | CN1980933A Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 06/13/2007 | CN1980929A 4-substituted piperidine derivatives |
| 06/13/2007 | CN1980920A Thiophene derivatives, their manufacture and use as pharmaceutical agents |
| 06/13/2007 | CN1980918A Substituted indazoles, compositions containing the same, and the preparation and use thereof |
| 06/13/2007 | CN1980913A Quinazolinedione derivatives as parp inhibitors |
| 06/13/2007 | CN1980898A Nucleoside derivatives and therapeutic uses therof |
| 06/13/2007 | CN1980891A Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS) |
| 06/13/2007 | CN1980886A Alpha-amino acid derivatives with antiinflammatory activity |
| 06/13/2007 | CN1980880A Substituted hydroxyacetophenon derivatives |
| 06/13/2007 | CN1980696A Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients |
| 06/13/2007 | CN1980690A Malignant tumor local infiltration inhibitor containing batroxobin |
| 06/13/2007 | CN1980675A Preparation for the treatment cancer |
| 06/13/2007 | CN1980672A Carboline derivatives useful in the inhibition of angiogenesis |
| 06/13/2007 | CN1980671A Liposome preparation containing slightly water-soluble camptothecin |
| 06/13/2007 | CN1980661A Cationic bacteriochlorophyll derivatives and uses thereof |
| 06/13/2007 | CN1978661A Method for quickly screening anti-tumour active substance from natural product |
| 06/13/2007 | CN1978656A Induced differentiation of hemopoietic stem/progenitor cell into erythroid progenitor cells |
| 06/13/2007 | CN1978459A Compound Ananaside A, and its preparing method and anti-tumour use |
| 06/13/2007 | CN1978448A 10-hydroxy camptothecin arginine salt, and its preparing method and use |
| 06/13/2007 | CN1978447A 10-hydroxy camptothecin arginine salt, and its preparing method and use |
| 06/13/2007 | CN1977974A Indulion cyclodextrin/hydroxy camptothecin medicinal composition and its preparing method |
| 06/13/2007 | CN1977972A Anti tumour drug oral colon targeting preparation and its preparing method |
| 06/13/2007 | CN1977971A Mutant forms of cholera holotoxin as an adjuvant |
| 06/13/2007 | CN1977967A Injection preparation and use |
| 06/13/2007 | CN1977956A Chinse medicine for anti-cancer and treating cancer |
| 06/13/2007 | CN1977945A Method for extracting active ingredient from red ginseng and lilyturf root |
| 06/13/2007 | CN1977935A Medicinal composition for treating benigh leiomyoma |
| 06/13/2007 | CN1977920A Chinesemedicine prescription for treating esophageal cancer |
| 06/13/2007 | CN1977878A Chinese medicine composition and its use |
| 06/13/2007 | CN1977869A Radix actinidiae argutae extract and its anticanceruse |
| 06/13/2007 | CN1977864A Novel medicine for preventing early cervical cancer rubra Nocardia preparation and use |
| 06/13/2007 | CN1977863A Use of gekko powder for preparing medicine for treating colon adeno carcinoma |
| 06/13/2007 | CN1977855A Medicinal composition containing mangiferin and its preparing method |
| 06/13/2007 | CN1977832A Novel sterile powder injection containing sodium new houttuyfonate orits receivable salt or derivative |
| 06/13/2007 | CN1321134C Hetergeneous product of bio-active protein and its preparing process |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1321127C Iodine (I)-23-hydroxyl betulinic acid, rpeparation method and application thereof |
| 06/13/2007 | CN1321120C Phenoxazones, preparing process and pharmaceutical uses thereof |
| 06/13/2007 | CN1321116C Novel azepane derivatives |
| 06/13/2007 | CN1321106C New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 06/13/2007 | CN1321105C Derivative in hydroxy anthraquinones category and application |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/13/2007 | CN1320923C Cancer vaccine contg. cancer antigen based on tumor suppressor gene WT1 product and cationic liposomes |
| 06/13/2007 | CN1320917C Dripping pills of 'Xiao Chaihu' |
| 06/13/2007 | CN1320896C Dangshen astragalus composition for regulating immunity and its preparation method |
| 06/13/2007 | CN1320887C Methotrexate oral disintegrating tablet and its preparation method |
| 06/13/2007 | CN1320882C Use of honokiol in preparation of target drug for tumour |